• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个错义多态性(rs11466653,Met326Thr)的 toll-like receptor 10 (TLR10)与韩国人群甲状腺乳头状癌的肿瘤大小有关。

A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population.

机构信息

Kohwang Medical Research Institute, School of Medicine, Kyung Hee University, Seoul, 130-701, Korea.

出版信息

Endocrine. 2013 Feb;43(1):161-9. doi: 10.1007/s12020-012-9783-z. Epub 2012 Nov 3.

DOI:10.1007/s12020-012-9783-z
PMID:23124277
Abstract

Toll-like receptors (TLRs) are important components of innate immune response. The aim of this study was to investigate whether TLR gene cluster (TLR10-TLR1-TLR6) polymorphisms are associated with the etiology of papillary thyroid carcinoma (PTC) and its clinicopathologic characteristics. We recruited 94 PTC patients and 325 control subjects. Genotypes for each SNP were determined by direct sequencing. SNPStats and SPSS 18.0 were used to evaluate odds ratios (ORs), 95 % confidence intervals (CIs), and P values. Multiple logistic regression analyzes of genetic data were performed. The missense SNP rs11466653 was associated with small tumor size (<1 cm) in PTC. The frequency of the rs11466653 T allele was higher in PTC patients with tumors <1 cm in size than in the control group (95.8 vs. 87.2 %; P = 0.021, OR = 0.30, 95 % CI = 0.11-0.83). The T allele of rs11466653 (T/C, Met326Thr) in TLR10 may be a risk factor for the development of tumors in PTC in the Korean population.

摘要

Toll 样受体(TLRs)是先天免疫反应的重要组成部分。本研究旨在探讨 TLR 基因簇(TLR10-TLR1-TLR6)多态性是否与甲状腺乳头状癌(PTC)的病因及其临床病理特征有关。我们招募了 94 名 PTC 患者和 325 名对照者。通过直接测序确定每个 SNP 的基因型。使用 SNPStats 和 SPSS 18.0 来评估比值比(OR)、95%置信区间(CI)和 P 值。对遗传数据进行了多元逻辑回归分析。错义 SNP rs11466653 与 PTC 中的小肿瘤大小(<1 cm)有关。在肿瘤大小<1 cm 的 PTC 患者中,rs11466653 T 等位基因的频率高于对照组(95.8%比 87.2%;P = 0.021,OR = 0.30,95%CI = 0.11-0.83)。TLR10 中的 rs11466653(T/C,Met326Thr)T 等位基因可能是韩国人群 PTC 肿瘤发生的危险因素。

相似文献

1
A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population.一个错义多态性(rs11466653,Met326Thr)的 toll-like receptor 10 (TLR10)与韩国人群甲状腺乳头状癌的肿瘤大小有关。
Endocrine. 2013 Feb;43(1):161-9. doi: 10.1007/s12020-012-9783-z. Epub 2012 Nov 3.
2
Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population.Toll 样受体 2 多态性与韩国人群甲状腺乳头状癌及临床病理特征的相关性。
J Korean Med Sci. 2012 Nov;27(11):1333-8. doi: 10.3346/jkms.2012.27.11.1333. Epub 2012 Oct 30.
3
Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.白细胞介素 1 受体,I 型(IL1R1)启动子多态性(rs2192752,-1028A/C)与韩国人群甲状腺乳头状癌位置的关系。
Int J Immunogenet. 2012 Dec;39(6):501-7. doi: 10.1111/j.1744-313X.2012.01125.x. Epub 2012 May 18.
4
Polymorphisms in TLR1, TLR6 and TLR10 genes and the risk of Graves' disease.TLR1、TLR6和TLR10基因多态性与格雷夫斯病风险
Autoimmunity. 2015 Feb;48(1):13-8. doi: 10.3109/08916934.2014.939269. Epub 2014 Jul 16.
5
Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.Toll样受体基因簇(TLR6、TLR1和TLR10)与前列腺癌之间的关联。
Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1982-9. doi: 10.1158/1055-9965.EPI-07-0325.
6
Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis.Toll样受体基因簇(TLR10-TLR1-TLR6)中的基因变异影响结节病的病程。
Tissue Antigens. 2012 Jan;79(1):25-32. doi: 10.1111/j.1399-0039.2011.01808.x.
7
Genomic organization and transcript profiling of the bovine toll-like receptor gene cluster TLR6-TLR1-TLR10.牛Toll样受体基因簇TLR6-TLR1-TLR10的基因组组织与转录谱分析
Gene. 2006 Dec 15;384:45-50. doi: 10.1016/j.gene.2006.06.027. Epub 2006 Jul 29.
8
Toll-like receptor 10 rs10004195 variation may be protective against Bacillus Calmette-Guérin osteitis after newborn vaccination.Toll 样受体 10 rs10004195 变异可能对新生儿接种卡介苗后骨炎有保护作用。
Acta Paediatr. 2021 May;110(5):1585-1590. doi: 10.1111/apa.15720. Epub 2020 Dec 20.
9
Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.X射线修复交叉互补基因3(XRCC3)基因多态性与中国汉族人群甲状腺乳头状癌易感性的关联
Tumour Biol. 2016 Jan;37(1):979-87. doi: 10.1007/s13277-015-3882-4. Epub 2015 Aug 12.
10
Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2.Toll 样受体 10 与克罗恩病易感性的关联,与 NOD2 无关。
Genes Immun. 2011 Dec;12(8):635-42. doi: 10.1038/gene.2011.41. Epub 2011 Jun 30.

引用本文的文献

1
Updates on Toll-Like Receptor 10 Research.Toll样受体10研究进展
Eur J Immunol. 2025 May;55(5):e202551840. doi: 10.1002/eji.202551840.
2
Structural modelling and dynamics of full-length of TLR10 sheds light on possible modes of dimerization, ligand binding and mechanism of action.全长TLR10的结构建模与动力学揭示了二聚化的可能模式、配体结合及作用机制。
Curr Res Struct Biol. 2023 Feb 18;5:100097. doi: 10.1016/j.crstbi.2023.100097. eCollection 2023.
3
TLR10 and Its Unique Anti-Inflammatory Properties and Potential Use as a Target in Therapeutics.

本文引用的文献

1
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009.韩国癌症统计数据:2009 年的发病率、死亡率、生存率和患病率。
Cancer Res Treat. 2012 Mar;44(1):11-24. doi: 10.4143/crt.2012.44.1.11. Epub 2012 Mar 31.
2
BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness.土耳其甲状腺乳头状癌患者 BRAF(V600E) 突变:与肿瘤侵袭性指标的强相关性。
Endocrine. 2012 Oct;42(2):404-10. doi: 10.1007/s12020-012-9651-x. Epub 2012 Mar 17.
3
The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan.
Toll样受体10及其独特的抗炎特性与作为治疗靶点的潜在用途。
Immune Netw. 2020 Apr 23;20(3):e21. doi: 10.4110/in.2020.20.e21. eCollection 2020 Jun.
4
Association of Gene Polymorphism rs3027898 With Papillary Cancer Restricted to the Thyroid Gland: A Pilot Study.基因多态性 rs3027898 与仅局限于甲状腺的甲状腺乳头状癌的相关性:一项初步研究。
In Vivo. 2019 Nov-Dec;33(6):2281-2285. doi: 10.21873/invivo.11734.
5
Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma.HBME-1高表达在甲状腺乳头状癌中的诊断意义
Tumour Biol. 2016 Jul;37(7):8715-20. doi: 10.1007/s13277-015-4169-5. Epub 2016 Jan 7.
6
Association of BID SNPs (rs8190315 and rs2072392) and clinical features of benign prostate hyperplasia in Korean population.韩国人群中BID基因单核苷酸多态性(rs8190315和rs2072392)与良性前列腺增生临床特征的关联
J Exerc Rehabil. 2014 Dec 31;10(6):383-8. doi: 10.12965/jer.140168. eCollection 2014 Dec.
7
Toll-like receptor 10-1-6 gene cluster polymorphisms are not associated with benign prostatic hyperplasia in korean population.Toll 样受体 10-1-6 基因簇多态性与韩国人群良性前列腺增生无关。
Int Neurourol J. 2014 Mar;18(1):10-5. doi: 10.5213/inj.2014.18.1.10. Epub 2014 Mar 31.
8
Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cells.癌症(干细胞)中的治疗耐药机制,重点关注甲状腺癌细胞。
Front Endocrinol (Lausanne). 2014 Mar 25;5:37. doi: 10.3389/fendo.2014.00037. eCollection 2014.
9
Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer.人类Toll样受体(TLR)基因单核苷酸多态性与感染性疾病、炎症性疾病及癌症的相关性
Genes Immun. 2014 Apr;15(4):199-209. doi: 10.1038/gene.2014.10. Epub 2014 Mar 13.
10
Association of TLR6 single nucleotide polymorphisms and clinical features of ischemic stroke in Korean population.韩国人群中TLR6单核苷酸多态性与缺血性中风临床特征的关联
J Exerc Rehabil. 2013 Dec 31;9(6):526-31. doi: 10.12965/jer.130076. eCollection 2013.
Toll 样受体和适应性免疫在克氏锥虫原生动物引发的保护性或病理性免疫反应发展中的作用。
Future Microbiol. 2011 Dec;6(12):1521-33. doi: 10.2217/fmb.11.122.
4
Role of Toll-like Receptor 3 Variants in Aspirin-Exacerbated Respiratory Disease.Toll 样受体 3 变异在阿司匹林加重性呼吸道疾病中的作用。
Allergy Asthma Immunol Res. 2011 Apr;3(2):123-7. doi: 10.4168/aair.2011.3.2.123. Epub 2010 Oct 14.
5
[BRAF(T1799A) mutation in the primary tumor as a marker of risk, recurrence, or persistence of papillary thyroid carcinoma].[原发性肿瘤中的BRAF(T1799A)突变作为乳头状甲状腺癌风险、复发或持续存在的标志物]
Endocrinol Nutr. 2011 Apr;58(4):175-84. doi: 10.1016/j.endonu.2011.02.006.
6
Arg753Gln polymorphism of the human Toll-like receptor 2 gene from infection to disease in pediatric tuberculosis.人类 Toll 样受体 2 基因 Arg753Gln 多态性与儿童结核病的感染及发病。
Hum Immunol. 2011 May;72(5):440-5. doi: 10.1016/j.humimm.2011.02.001. Epub 2011 Feb 12.
7
TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer.TLR-3 多态性是 II 期结直肠癌的独立预后标志物。
Eur J Cancer. 2011 May;47(8):1203-10. doi: 10.1016/j.ejca.2010.12.011. Epub 2011 Jan 14.
8
Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes.甲状腺乳头癌中 VEGF-A 的单核苷酸多态性和 mRNA 表达:侵袭表型的潜在标志物。
Eur J Surg Oncol. 2011 Jan;37(1):93-9. doi: 10.1016/j.ejso.2010.10.010. Epub 2010 Nov 18.
9
Role of PTPRJ genotype in papillary thyroid carcinoma risk.PTPRJ 基因型在甲状腺乳头状癌风险中的作用。
Endocr Relat Cancer. 2010 Oct 29;17(4):1001-6. doi: 10.1677/ERC-10-0143. Print 2010 Dec.
10
Polymorphisms in Toll-like receptor genes--implications for prostate cancer development.Toll样受体基因多态性——对前列腺癌发展的影响。
Coll Antropol. 2010 Jun;34(2):779-83.